Request Your Free Trend Report Now:

"Inside the Market Strategies of Today's Drugmakers"

Explore the full range of market forces shaping big pharma’s commercialization strategies in this Trendline.

Patent protection will run out later this decade for many multibillion-dollar medicines and will force their large pharmaceutical makers to find new products and markets. Explore some of the most important trends shaping the largest drugmakers’ market strategies in this Trendline.

INCLUDED IN THIS TRENDLINE

• A new, non-opioid pain drug is here. Getting it to patients could be agony.
• Ozempic, Ibrance among next drugs picked by Medicare for price talks
• Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.

Offered Free by: BioPharma Dive and Phil Inc
See All Resources from: BioPharma Dive and Phil Inc